Skip to main content
. 2020 Apr 1;56(4):158. doi: 10.3390/medicina56040158

Table 5.

Differences and changes in biomarkers.

Items (Units) Groups ANOVA (p)
CON (n = 12) EMSG (n = 13) G T G × T
IL-6 Pre 14.29 ± 7.52 14.51 ± 7.14 0.236 0.223 0.051
(pg/mL) Post 15.41 ± 3.79 9.95 ± 6.31
TNF-a Pre 28.21 ± 8.51 27.28 ± 12.35 0.039 0.555 0.001
(pg/mL) Post 36.68 ± 11.68 20.77 ± 8.64
CRP Pre 34.33 ± 15.80 33.19 ± 10.30 0.001 0.013 0.001
(pg/mL) Post 54.65 ± 11.66 26.65 ± 8.13
RSTN Pre 5.92 ± 1.98 5.56 ± 2.55 0.001 0.859 0.005
(ng/mL) Post 8.43 ± 4.06 3.33 ± 1.09
CEA Pre 2.12 ± 1.21 2.24 ± 0.66 0.034 0.864 0.001
(ng/mL) Post 2.88 ± 1.07 1.42 ± 0.19
CK Pre 222.92 ± 67.13 218.38 ± 51.82 0.869 0.530 0.761
(IU/L) Post 230.33 ± 80.64 239.69 ± 65.85
HDL-C Pre 50.92 ± 9.82 47.08 ± 9.99 0.819 0.992 0.008
(mg/dL) Post 46.33 ± 8.63 51.69 ± 7.70
LDL-C Pre 134.17 ± 43.47 145.31 ± 35.44 0.332 0.005 0.009
(mg/dL) Post 131.83 ± 36.60 97.54 ± 23.88

All data represents the mean ± standard deviation. IL-6, TNF, CRP, RSTN, CEA, CK, HDL-C, and LDL-C mean interleukin-6, tumor necrosis factor, C-reactive protein, resistin, carcinoembryonic antigen, creatine kinase, high-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol, respectively.